Overview

  • Product nameAnti-SerpinB9 antibody [7D8]
    See all SerpinB9 primary antibodies
  • Description
    Mouse monoclonal [7D8] to SerpinB9
  • Tested applicationsSuitable for: WB, Flow Cytmore details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    Recombinant Human SerpinB9 produced in P. pastoris.

  • Positive control
    • Human Lymphocytes or Granulocytes

Properties

Applications

Our Abpromise guarantee covers the use of ab112220 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB Use at an assay dependent concentration. Predicted molecular weight: 42 kDa.
Flow Cyt Use 0.5µg for 106 cells. ab170190-Mouse monoclonal IgG1, is suitable for use as an isotype control with this antibody.

Target

  • FunctionGranzyme B inhibitor.
  • Sequence similaritiesBelongs to the serpin family. Ov-serpin subfamily.
  • Cellular localizationCytoplasm.
  • Information by UniProt
  • Database links
  • Alternative names
    • CAP 3 antibody
    • CAP-3 antibody
    • CAP3 antibody
    • Cytoplasmic antiproteinase 3 antibody
    • Peptidase inhibitor 9 antibody
    • PI-9 antibody
    • PI9 antibody
    • Protease inhibitor 9 antibody
    • Protease inhibitor 9 (ovalbumin type) antibody
    • Serine (or cysteine) proteinase inhibitor clade B (ovalbumin) member 9 antibody
    • Serpin B9 antibody
    • Serpin peptidase inhibitor clade B (ovalbumin) member 9 antibody
    • Serpin peptidase inhibitor clade B member 9 antibody
    • SERPINB9 antibody
    • SPB9_HUMAN antibody
    see all

Anti-SerpinB9 antibody [7D8] images

  • Flow cytometry staining of SerpinB9 in Human Lymphocytes and Granulocytes using ab112220 at 0.5 µg for 106 cells.

    Percentage of cells stained above control: Lymphocytes: 22% above control; Granulocytes: 14% above control

References for Anti-SerpinB9 antibody [7D8] (ab112220)

This product has been referenced in:
  • Deisting W  et al. Impact of Diverse Immune Evasion Mechanisms of Cancer Cells on T Cells Engaged by EpCAM/CD3-Bispecific Antibody Construct AMG 110. PLoS One 10:e0141669 (2015). WB . Read more (PubMed: 26510188) »

See 1 Publication for this product

Product Wall

Thank you for contacting us.

These two products are derived from the same clone, so in theory, it is the same product. We source it from different labs, and it looks like ab46533 has been better characterized so far. Actually, it wouldn't be a...

Read More

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"